THERAPY TO PREVENT HEPATOCELLULAR CARCINOMA IN PEOPLE WITH LIVER CIRRHOSIS
Professor John Olynyk, Liver Specialist, Gastroenterologist & Hepatologist,
Fiona Stanley and Fremantle Hospitals
South Metropolitan Health Service, Western Australia &
Associate Director, Clinical Engagement,
Curtin Medical Research Institute, Curtin University, Western Australia
RESEARCHER PROFILE
Filmed in Perth, Western Australia | February 2026
Professor John Olynyk is a Gastroenterologist & Hepatologist with over 30 years’ experience, primarily at The Fiona Stanley & Fremantle Hospital Group. He planned the Gastroenterology and Hepatology Service for the Fiona Stanley Hospital and was Head Department from 2010 until 2020.
Professor John Olynyk was appointed as Associate Dean and Head of the Medical Discipline at Curtin University in 2023 until 2025 and is now Associate Director, Clinical Engagement, Curtin Medical Research Institute, Curtin University.
Professor John Olynyk has a long and productive history of research in the field of haemochromatosis, liver disease and iron metabolism. He has sustained 27 years of continuous funding from the NHMRC and published over 270 peer reviewed publications with nearly 20,000 citations. He is patron of Haemochromatosis Australia and currently serves on the Royal Australasian College of Physicians overseas trained physicians assessment panel.
He has been a member of multiple national and international professional organisations. He was a keynote speaker at the UK Liver Cancer Meeting at Cambridge University in 2024. Currently he is leading a multicentre, international NHMRC-funded clinical trial examining whether aspirin therapy can prevent hepatocellular carcinoma in people with cirrhosis.
Source: Supplied
https://orcid.org/0000-0003-0417-3411
-
Dr Kelly-Anne Masterman
RESEARCH IN NEEDLE-FREE VACCINE DELIVERY SYSTEM
@ VAXXAS, BRISBANE, QUEENSLAND, AUSTRALIA -
Electrical stimulation on organic conductors
Professor Gordon Wallace AO is the Founder and Director of the Intelligent Polymer Research Institute (IPRI) at the University of Wollongong and Founding Director of the Australian National Fabrication Facility (ANFF) Materials Node. He was previously the Executive Director of the ARC Centre of Excellence for Electromaterials Science (ACES).
-
Life-changing donor milk for preterm babies
Dr Laura Klein is National Milk Research Leader at Australian Red Cross Lifeblood. Australian Red Cross Lifeblood is funded by Australian governments to provide life-giving blood, plasma, and transplantation and biological products.
Dr Klein works with clinicians and researchers across Australia to understand how donated breast milk can be used to improve outcomes for vulnerable babies. She’s passionate about generating evidence to improve the products and services that milk banks provide to donors and the families who receive donated breast milk.
